Terug
Dagbereik
€ 1,57
€ 1,57
52-Weeksbereik
€ 0,81
€ 1,85
Volume
1.000
50D / 200D Gem.
€ 1,45
/
€ 1,37
Vorige Slotkoers
€ 1,57
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -13,5 | 0,3 |
| P/B | 4,8 | 3,0 |
| ROE % | -31,6 | 3,7 |
| Net Margin % | -20,8 | 3,8 |
| Rev Growth 5Y % | 12,4 | 10,0 |
| D/E | 2,8 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,09
€ 0,08 – € 0,09
|
1,43B | 1 |
| FY2026 |
€ 0,05
€ 0,05 – € 0,05
|
1,26B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 12,40% annually over 5 years — strong growth
Debt/Equity of 2,79 — high leverage
Negative free cash flow of -158,54M
PEG of 0,13 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,51%
Groei
Revenue Growth (5Y)
12,40%
Revenue (1Y)8,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-31,58%
ROIC-4,13%
Net Margin-20,76%
Op. Margin-12,17%
Veiligheid
Debt / Equity
2,79
Current Ratio1,47
Interest Coverage-1,18
Waardering
P/E Ratio
-13,49
Forward P/EN/A
P/B Ratio4,81
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,89% | Revenue Growth (3Y) | 10,96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,04B | Net Income (TTM) | -214,92M |
| ROE | -31,58% | ROA | -5,92% |
| Gross Margin | 55,45% | Operating Margin | -12,17% |
| Net Margin | -20,76% | Free Cash Flow (TTM) | -158,54M |
| ROIC | -4,13% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,79 | Current Ratio | 1,47 |
| Interest Coverage | -1,18 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13,49 | Forward P/E | N/A |
| P/B Ratio | 4,81 | P/S Ratio | 2,80 |
| PEG Ratio | 0,13 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5,47% | ||
| Market Cap | 2,90B | Enterprise Value | 3,87B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,04B | 950,73M | 840,83M | 778,64M | 648,73M |
| Net Income | -214,92M | -477,63M | -436,52M | -276,48M | -191,25M |
| EPS (Diluted) | -0,12 | -0,27 | -0,25 | -0,16 | -0,11 |
| Gross Profit | 574,09M | 532,10M | 501,77M | 491,77M | 436,03M |
| Operating Income | -125,98M | -516,17M | -506,57M | -293,62M | -167,14M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3,63B | 3,93B | 3,99B | 4,38B | 2,47B |
| Total Liabilities | 2,49B | 2,53B | 2,20B | 2,16B | 1,08B |
| Shareholders' Equity | 603,22M | 757,82M | 1,14B | 1,49B | 1,13B |
| Total Debt | 1,69B | 1,70B | 1,47B | 1,24B | 296,31M |
| Cash & Equivalents | 713,00M | 1,02B | 1,20B | 1,75B | 1,00B |
| Current Assets | 1,74B | 2,01B | 1,94B | 2,39B | 1,48B |
| Current Liabilities | 1,18B | 1,27B | 662,13M | 546,76M | 519,38M |